Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 283 entries
View as:

The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05645484 Org: User:
Start: 09/02/22 End: 08/31/23 Due: 08/31/24

18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04996927 Org: User:
Start: 06/01/21 End: 06/01/23 Due: 06/01/24

Effect of Inhaled Nitric Oxide on Pulmonary Ventilation/Perfusion Ratio Assessed by EIT in Patients With ARDS

Phase: N/A Priority: Normal
NCT ID: NCT05873647 Org: User:
Start: 05/01/23 End: 05/01/25 Due: 05/01/26

Different Algorithm Models to Predict Postoperative Pulmonary Complications in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT05671939 Org: User:
Start: 01/31/23 End: 03/31/23 Due: 03/31/24

Evaluate the Effect of Prone Ventilation on Ventilated-blood Flow Ratio in Patients With ARDS by EIT

Phase: N/A Priority: Normal
NCT ID: NCT06181539 Org: User:
Start: 07/01/23 End: 07/01/25 Due: 07/01/26

Prevention and Treatment of Perioperative Lung Injury in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT05701449 Org: User:
Start: 01/31/23 End: 12/31/23 Due: 12/31/24

The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06490211 Org: User:
Start: 11/20/23 End: 11/20/26 Due: 11/20/27

Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Postherpetic Neuralgia.

Phase: N/A Priority: Normal
NCT ID: NCT06290661 Org: User:
Start: 02/09/23 End: 06/30/25 Due: 06/30/26

CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06735495 Org: User:
Start: 11/04/24 End: 12/31/27 Due: 12/31/28

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06140966 Org: User:
Start: 10/20/23 End: 10/20/27 Due: 10/20/28

Treatment of Periodontal Disease in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05183321 Org: User:
Start: 06/01/24 End: 12/31/26 Due: 12/31/27

RIR and the Impact on Clinical Outcomes in Patients Undergoing PCI

Phase: N/A Priority: Normal
NCT ID: NCT05131750 Org: User:
Start: 05/06/21 End: 12/31/26 Due: 12/31/27

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

Phase: N/A Priority: Normal
NCT ID: NCT06922851 Org: User:
Start: 06/04/25 End: 06/30/28 Due: 06/30/29

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

Phase: N/A Priority: Normal
NCT ID: NCT02657460 Org: User:
Start: 01/31/16 End: 12/31/19 Due: 12/31/20

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06134193 Org: User:
Start: 11/30/23 End: 06/30/25 Due: 06/30/26

Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05020392 Org: User:
Start: 09/14/21 End: 10/13/24 Due: 10/13/25

Postoperative Pulmonary Complications Between Patients Undergoing Abdominal Surgery in Plateau and Plain Areas

Phase: N/A Priority: Normal
NCT ID: NCT05131009 Org: User:
Start: 11/30/21 End: 09/30/22 Due: 09/30/23

Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT)

Phase: N/A Priority: Normal
NCT ID: NCT05085054 Org: User:
Start: 06/01/22 End: 08/01/24 Due: 08/01/25

Step 2 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Phase: N/A Priority: Normal
NCT ID: NCT05782894 Org: User:
Start: 02/28/23 End: 11/25/23 Due: 11/25/24

Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04007978 Org: User:
Start: 08/05/19 End: 12/30/22 Due: 12/30/23

A Prospective Cohort Study on Ligation of Pancreatic Stump After Distal Pancreatectomy

Phase: N/A Priority: Normal
NCT ID: NCT06814249 Org: User:
Start: 11/21/24 End: 10/31/25 Due: 10/31/26

Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI

Phase: N/A Priority: Normal
NCT ID: NCT05130892 Org: User:
Start: 11/15/21 End: 02/01/23 Due: 02/01/24

Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT02933099 Org: User:
Start: 10/31/16 End: 12/31/18 Due: 12/31/19

Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis

Phase: N/A Priority: Normal
NCT ID: NCT06742008 Org: User:
Start: 12/17/24 End: 06/17/25 Due: 06/17/26

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06741995 Org: User:
Start: 12/17/24 End: 12/17/27 Due: 12/17/28